Hostname: page-component-89b8bd64d-ksp62 Total loading time: 0 Render date: 2026-05-08T14:08:23.520Z Has data issue: false hasContentIssue false

Time spent in the radiotherapy department for breast cancer treatment, pre-, mid- and post-COVID-19 pandemic (a 6-year, single-centre service review)

Published online by Cambridge University Press:  28 April 2025

Joseph Purden*
Affiliation:
Faculty of Medicine, Health and Life Sciences, Swansea University, Swansea, UK
Douglas Etheridge
Affiliation:
Department of Medical Physics and Clinical Engineering, South West Wales Cancer Centre, Singleton Hospital, Swansea Bay University Health Board, Swansea, UK
Christopher Rose
Affiliation:
Department of Medical Physics and Clinical Engineering, South West Wales Cancer Centre, Singleton Hospital, Swansea Bay University Health Board, Swansea, UK
Ryan Lewis
Affiliation:
Department of Medical Physics and Clinical Engineering, South West Wales Cancer Centre, Singleton Hospital, Swansea Bay University Health Board, Swansea, UK
*
Corresponding author: Joseph Purden; Email: J.M.C.Purden@Swansea.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

Before COVID-19, breast cancer patients in the UK typically received 15 radiotherapy (RT) fractions over three weeks. During the pandemic, adoption of a 5-fraction treatment prescription and more advanced treatment techniques like surface-guided RT, meant a change in the duration and number of hospital visits for patients accessing treatment. This work sought to understand how breast cancer patients’ time in the RT department has changed, between 2018 and 2023.

Methods:

Appointments for CT simulation, mould room, and RT, from January 2018 to December 2023, were extracted from the Mosaiq® Oncology Management System. Appointments lasting between 5 minutes and 5 hours were analysed. Total visit time was calculated from check-in to completion on the quality checklist.

Results:

In total, 29,523 attendances were analysed over 6 years. Average time spent in the department decreased during the pandemic but has since increased 12·4% above pre-COVID-19 levels. Early morning and late afternoon appointments resulted in the shortest visits, with early afternoon appointments leading to the longest visits. On average, patients spend the longest in the department on a Monday, and the least amount of time on a Friday. Friday was the least common day to start a 15-fraction treatment, whereas Tuesday and Friday were equally uncommon for the 5-fraction regime.

Conclusions:

During the COVID-19 pandemic, the number of visits a patient makes for breast cancer RT and related services dropped, and remained lower post-COVID-19, due to fewer treatment fractions being prescribed. Average time spent in the department initially decreased but has since increased beyond pre-COVID-19 levels.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press
Figure 0

Figure 1. Breast cancer patient visits for treatment, 2018–2023.

Figure 1

Table 1. Treatment plans for breast cancer created at South-West Wales Cancer Centre between 2018 and 2023

Figure 2

Figure 2. Average time in department for a fraction of radiotherapy to the breast.

Figure 3

Figure 3. Comparison of start day frequency for 5# and 15# breast radiotherapy.

Figure 4

Figure 4. (a) Average time spent in the department for breast radiotherapy, by day of the week and time of arrival, 15#s. (b) Average time spent in the department for breast radiotherapy, by day of the week and time of arrival, 5#s.